{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:01:45Z","timestamp":1787587305014,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12363-z","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:17:50Z","timestamp":1784276270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening and molecular characterization of plasmid-mediated fosfomycin resistance in Enterobacterales"],"prefix":"10.1007","volume":"53","author":[{"given":"Abdullah","family":"Tozluyurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"12363_CR1","doi-asserted-by":"crossref","unstructured":"Tozluyurt A (2026) Antimicrobial resistance and carbapenemase production among gram-negative bacteria in a newly established hospital. Naunyn Schmiedebergs Arch Pharmacol 399(8):1\u201310","DOI":"10.1007\/s00210-026-05158-3"},{"issue":"1","key":"12363_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12879-017-2785-y","volume":"17","author":"G C\u00f3rdoba","year":"2017","unstructured":"C\u00f3rdoba G, Holm A, Hansen F, Hammerum AM, Bjerrum L (2017) Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care. Denmark BMC Infect Dis 17(1):670","journal-title":"Denmark BMC Infect Dis"},{"issue":"5","key":"12363_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","volume":"34","author":"GC Schito","year":"2009","unstructured":"Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L et al (2009) The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 34(5):407\u2013413","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"12363_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/infdis\/jiz149","volume":"220","author":"KM Papp-Wallace","year":"2019","unstructured":"Papp-Wallace KM, Zeiser ET, Becka SA, Park S, Wilson BM, Winkler ML et al (2019) Ceftazidime-avibactam in combination with fosfomycin: a novel therapeutic strategy against multidrug-resistant Pseudomonas aeruginosa. J Infect Dis 220(4):666\u2013676","journal-title":"J Infect Dis"},{"issue":"7","key":"12363_CR5","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/jac\/dkaa095","volume":"75","author":"GT Cuba","year":"2020","unstructured":"Cuba GT, Rocha-Santos G, Cay\u00f4 R, Streling AP, Nodari CS, Gales AC et al (2020) In vitro synergy of ceftolozane\/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa. J Antimicrob Chemother 75(7):1874\u20131878","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"12363_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3103\/S0891416824700198","volume":"39","author":"A Tozluyurt","year":"2024","unstructured":"Tozluyurt A (2024) The Effectiveness of Aztreonam, Aztreonam-Avibactam, Cefiderocol on bla NDM-Producing E. coli Isolates. Mol Genet Microbiol Virol 39(2):158\u2013164","journal-title":"Mol Genet Microbiol Virol"},{"issue":"1","key":"12363_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dkg280","volume":"52","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G, Menday P (2003) Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO\u00b7 SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 52(1):128\u2013131","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"12363_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.51585\/gjm.2024.1.0028","volume":"4","author":"A Tozluyur","year":"2024","unstructured":"Tozluyur A (2024) Fosfomycin in the treatment of New Delhi Metallo-\u03b2-Lactamase-5 (blaNDM-5)-producing Escherichia coli infection. German J Microbiol 4(1):1\u20135","journal-title":"German J Microbiol"},{"issue":"4","key":"12363_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.36519\/idcm.2022.163","volume":"4","author":"Y Tanr\u0131verdi-\u00c7ayc\u0131","year":"2022","unstructured":"Tanr\u0131verdi-\u00c7ayc\u0131 Y, G\u00fcne DB, Ertokatl\u0131 M, Hac\u0131emino\u011flu-\u00dclker K, Birinci A (2022) Prevalence of fosfomycin resistance among Enterobacterales isolates in a tertiary care hospital from Turkey. Infect Dis Clin Microbiol 4(4):252","journal-title":"Infect Dis Clin Microbiol"},{"issue":"5","key":"12363_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00430-022-00749-2","volume":"211","author":"E R\u00edos","year":"2022","unstructured":"R\u00edos E, del Carmen L\u00f3pez Diaz M, Culebras E, Rodr\u00edguez-Avial I, Rodr\u00edguez-Avial C (2022) Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum \u03b2-lactamase-production in urinary isolates of Escherichia coli. Med Microbiol Immunol 211(5):269\u2013272","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"12363_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.biochem.78.091707.100215","volume":"78","author":"WW Metcalf","year":"2009","unstructured":"Metcalf WW, Van Der Donk WA (2009) Biosynthesis of phosphonic and phosphinic acid natural products. Annu Rev Biochem 78(1):65\u201394","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"12363_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","volume":"235","author":"FM Kahan","year":"1974","unstructured":"Kahan FM, Kahan JS, Cassidy PJ, Kropp H (1974) The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 235(1):364\u2013386","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"12363_CR13","doi-asserted-by":"publisher","first-page":"e01446","DOI":"10.1128\/AAC.01446-21","volume":"66","author":"D Zheng","year":"2022","unstructured":"Zheng D, Bergen PJ, Landersdorfer CB, Hirsch EB (2022) Differences in fosfomycin resistance mechanisms between Pseudomonas aeruginosa and Enterobacterales. Antimicrob Agents Chemother 66(2):e01446\u2013e01421","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"12363_CR14","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/AAC.06122-11","volume":"56","author":"A Couce","year":"2012","unstructured":"Couce A, Briales A, Rodr\u00edguez-Rojas A, Costas C, Pascual \u00c1, Bl\u00e1zquez J (2012) Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost. Antimicrob Agents Chemother 56(5):2767\u20132769","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"12363_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/lam.12366","volume":"60","author":"Y Ma","year":"2015","unstructured":"Ma Y, Xu X, Guo Q, Wang P, Wang W, Wang M (2015) Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli. Lett Appl Microbiol 60(3):259\u2013264","journal-title":"Lett Appl Microbiol"},{"issue":"3","key":"12363_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/AAC.46.3.940-940.2002","volume":"46","author":"RG Nelson","year":"2002","unstructured":"Nelson RG, Rosowsky A (2002) Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations. Antimicrob Agents Chemother 46(3):940","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12363_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/BJ20121541","volume":"451","author":"AA Roberts","year":"2013","unstructured":"Roberts AA, Sharma SV, Strankman AW, Duran SR, Rawat M, Hamilton CJ (2013) Mechanistic studies of FosB: a divalent-metal-dependent bacillithiol-S-transferase that mediates fosfomycin resistance in Staphylococcus aureus. Biochem J 451(1):69\u201379","journal-title":"Biochem J"},{"issue":"27","key":"12363_CR18","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1021\/bi700625p","volume":"46","author":"KL Fillgrove","year":"2007","unstructured":"Fillgrove KL, Pakhomova S, Schaab MR, Newcomer ME, Armstrong RN (2007) Structure and mechanism of the genomically encoded fosfomycin resistance protein, FosX, from Listeria monocytogenes. Biochemistry 46(27):8110\u20138120","journal-title":"Biochemistry"},{"key":"12363_CR19","doi-asserted-by":"publisher","unstructured":"Ito R, Mustapha MM, Tomich AD, Callaghan JD, McElheny CL, Mettus RT et al (2017) Widespread fosfomycin resistance in Gram-negative bacteria attributable to the chromosomal fosA gene. MBio 8(4). https:\/\/doi.org\/10.1128\/mbio.00749-17","DOI":"10.1128\/mbio.00749-17"},{"issue":"4","key":"12363_CR20","doi-asserted-by":"publisher","first-page":"e01673","DOI":"10.1128\/msystems.01673-24","volume":"10","author":"A Munir","year":"2025","unstructured":"Munir A, Lu X, Humak F, K\u00fcrekci C, Mahmood MS, Gul S et al (2025) Emergence of plasmid-mediated fosfomycin resistance among Escherichia coli harboring fosA4, tet (X4), and mcr-1 genes in wild birds. Msystems 10(4):e01673\u2013e01624","journal-title":"Msystems"},{"issue":"6","key":"12363_CR21","doi-asserted-by":"publisher","first-page":"e01877","DOI":"10.1128\/aac.01877-25","volume":"70","author":"MA Mateo-Vargas","year":"2026","unstructured":"Mateo-Vargas MA, Fern\u00e1ndez-Cuenca F, L\u00f3pez-Cerero L, Rodr\u00edguez-Iglesias M, Gal\u00e1n-S\u00e1nchez F (2026) Description of a chromosomal fosA6 tandem multicopy fragment and its in vivo evolution in consecutive KPC-producing Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 70(6):e01877\u2013e01825","journal-title":"Antimicrob Agents Chemother"},{"key":"12363_CR22","unstructured":"Control CfD (2019) Prevention. CDC\/NHSN surveillance definitions for specific types of infections. CDC website: https:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/17pscNosInfDef_current.pdf. Accessed. 2018;25"},{"key":"12363_CR23","doi-asserted-by":"crossref","unstructured":"Tozluyurt A Antimicrobial resistance and carbapenemase production among gram-negative bacteria in a newly established hospital. Naunyn-Schmiedeberg\u2019s archives of pharmacology 399(8):12775\u201312784","DOI":"10.1007\/s00210-026-05158-3"},{"issue":"9","key":"12363_CR24","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1128\/JCM.01094-14","volume":"52","author":"G Nakamura","year":"2014","unstructured":"Nakamura G, Wachino J-i, Sato N, Kimura K, Yamada K, Jin W et al (2014) Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases. J Clin Microbiol 52(9):3175\u20133179","journal-title":"J Clin Microbiol"},{"key":"12363_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jgar.2023.08.001","volume":"35","author":"T Grilo","year":"2023","unstructured":"Grilo T, Freire S, Miguel B, Martins LN, Menezes MF, Nordmann P et al (2023) Occurrence of plasmid-mediated fosfomycin resistance (fos genes) among Escherichia coli isolates, Portugal. J Global Antimicrob Resist 35:342\u2013346","journal-title":"J Global Antimicrob Resist"},{"issue":"1","key":"12363_CR26","doi-asserted-by":"publisher","first-page":"01531","DOI":"10.1128\/jcm","volume":"57","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L, Mueller L (2019) Rapid detection of fosfomycin resistance in Escherichia coli. J Clin Microbiol 57(1):01531\u201301518. https:\/\/doi.org\/10.1128\/jcm","journal-title":"J Clin Microbiol"},{"issue":"5","key":"12363_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10096-019-03531-0","volume":"38","author":"L Mueller","year":"2019","unstructured":"Mueller L, Cimen C, Poirel L, Descombes M-C, Nordmann P (2019) Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland. Eur J Clin Microbiol Infect Dis 38(5):945\u2013949","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12363_CR28","first-page":"000333370346035","volume":"10","author":"VSA Salamov","year":"2011","unstructured":"Salamov VSA, Solovyevand A (2011) Automatic annotation of microbial genomes and metagenomic sequences. Metagenomics and its applications in agriculture. Biomed Environ Stud 10:0003333703460353","journal-title":"Biomed Environ Stud"},{"issue":"10","key":"12363_CR29","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.1128\/AAC.01201-16","volume":"60","author":"N Kieffer","year":"2016","unstructured":"Kieffer N, Nordmann P, Aires-de-Sousa M, Poirel L (2016) High prevalence of carbapenemase-producing Enterobacteriaceae among hospitalized children in Luanda. Angola Antimicrob agents Chemother 60(10):6189\u20136192","journal-title":"Angola Antimicrob agents Chemother"},{"issue":"1","key":"12363_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13756-017-0250-8","volume":"6","author":"K Zurfluh","year":"2017","unstructured":"Zurfluh K, N\u00fcesch-Inderbinen M, Klumpp J, Poirel L, Nordmann P, Stephan R (2017) Key features of mcr-1-bearing plasmids from Escherichia coli isolated from humans and food. Antimicrob Resist Infect Control 6(1):91","journal-title":"Antimicrob Resist Infect Control"},{"key":"12363_CR31","doi-asserted-by":"crossref","unstructured":"Ehrt S, Schnappinger D (2003) Isolation of plasmids from E. coli by alkaline lysis. In: E. coli Plasmid Vectors: Methods and Applications. Springer, pp. 75\u201378","DOI":"10.1385\/1-59259-409-3:75"},{"issue":"7","key":"12363_CR32","doi-asserted-by":"publisher","first-page":"002039","DOI":"10.1099\/jmm.0.002039","volume":"74","author":"P Thakur","year":"2025","unstructured":"Thakur P, Kaur N, Chauhan S, Abdelmonem R, Amponsah RD (2025) Fosfomycin resistance in extended-spectrum beta-lactamase producing Escherichia coli isolated from urinary tract-infected patients in a tertiary care hospital. J Med Microbiol 74(7):002039","journal-title":"J Med Microbiol"},{"key":"12363_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jgar.2023.09.003","volume":"35","author":"J Findlay","year":"2023","unstructured":"Findlay J, Sierra R, Raro OHF, Aires-de-Sousa M, Andrey DO, Nordmann P (2023) Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin. J global Antimicrob Resist 35:137\u2013142","journal-title":"J global Antimicrob Resist"},{"issue":"2","key":"12363_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3201\/eid2202.151301","volume":"22","author":"AC Mendes","year":"2016","unstructured":"Mendes AC, Rodrigues C, Pires J, Amorim J, Ramos MH, Novais \u00c2 et al (2016) Importation of fosfomycin resistance fosA3 gene to Europe. Emerg Infect Dis 22(2):346","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"12363_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/AAC.18.2.215","volume":"18","author":"C Mendoza","year":"1980","unstructured":"Mendoza C, Garcia J, Llaneza J, Mendez F, Hardisson C, Ortiz J (1980) Plasmid-determined resistance to fosfomycin in Serratia marcescens. Antimicrob Agents Chemother 18(2):215\u2013219","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12363_CR36","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1038\/s41467-019-12359-3","volume":"10","author":"KM Mickiewicz","year":"2019","unstructured":"Mickiewicz KM, Kawai Y, Drage L, Gomes MC, Davison F, Pickard R et al (2019) Possible role of L-form switching in recurrent urinary tract infection. Nat Commun 10(1):4379","journal-title":"Nat Commun"},{"key":"12363_CR37","doi-asserted-by":"crossref","unstructured":"Elliott Z, Barry K, Cox H, Stoesser N, Carroll J, Vegesana K et al (2019) The Role of fosAin Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates","DOI":"10.1128\/JCM.00634-19"},{"key":"12363_CR38","doi-asserted-by":"publisher","unstructured":"Kieffer N, Poirel L, Mueller L, Mancini S, Nordmann P (2020) IS Ecp1-mediated transposition leads to fosfomycin and broad-spectrum cephalosporin resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 64(5). https:\/\/doi.org\/10.1128\/aac00150-20","DOI":"10.1128\/aac00150-20"},{"issue":"3","key":"12363_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1128\/AAC.01488-15","volume":"60","author":"D-R Xiang","year":"2016","unstructured":"Xiang D-R, Li J-J, Sheng Z-K, Yu H-Y, Deng M, Bi S et al (2016) Complete Sequence of a Novel IncR-F33: A\u2013: B\u2013Plasmid, pKP1034, Harboring fosA3, bla KPC-2, bla CTX-M-65, bla SHV-12, and rmtB from an Epidemic Klebsiella pneumoniae Sequence Type 11 Strain in China. Antimicrob Agents Chemother 60(3):1343\u20131348","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12363_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5578\/mb.20124","volume":"55","author":"S S\u00fcz\u00fck Y\u0131ld\u0131z","year":"2021","unstructured":"S\u00fcz\u00fck Y\u0131ld\u0131z S, \u015eim\u015fek H, Bakkalo\u011flu Z, Numano\u011flu \u00c7evik Y, Hekimo\u011flu C, K\u0131l\u0131\u00e7 S et al (2021) T\u00fcrkiye\u2019de 2019 y\u0131l\u0131 i\u00e7inde izole edilen Escherichia coli ve Klebsiella pneumoniae izolatlar\u0131nda karbapenemaz epidemiyolojisi. Mikrobiyol Bul 55(1):1\u201316","journal-title":"Mikrobiyol Bul"},{"issue":"5","key":"12363_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10096-022-04425-4","volume":"41","author":"B Isler","year":"2022","unstructured":"Isler B, \u00d6zer B, \u00c7\u0131nar G, Aslan AT, Vatansever C, Falconer C et al (2022) Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting. Eur J Clin Microbiol Infect Dis 41(5):841\u2013847","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"12363_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/antibiotics13050435","volume":"13","author":"DS Lazar","year":"2024","unstructured":"Lazar DS, Nica M, Dascalu A, Oprisan C, Albu O, Codreanu DR et al (2024) Carbapenem-Resistant NDM and OXA-48-like Producing K. pneumoniae: From Menacing Superbug to a Mundane Bacteria; A Retrospective Study in a Romanian Tertiary Hospital. Antibiotics 13(5):435","journal-title":"Antibiotics"},{"key":"12363_CR43","doi-asserted-by":"crossref","unstructured":"Sousa-Carmo RR, Becerra J, Sano E, Fontana H, Martins-Gon\u00e7alves T, Queiroga G et al (2025) Tracking pandemic pathogens from wastewater surveillance in international airports: Klebsiella pneumoniae ST16 coproducing NDM-4 and OXA-181 arriving in South America. Lancet Microbe 6(4)","DOI":"10.1016\/j.lanmic.2024.101071"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12363-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:17:54Z","timestamp":1784276274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12363-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12363"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12363-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"7 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Konya Kulu Regional State Hospital, IRB No: 20250183.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study. For participants who were minors (under 18 years of age), written informed consent was obtained from their parents or legal guardians.","order":3,"name":"Ethics","label":"<b>Informed consent<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1195"}}